The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Brannelly Paul since 2008.
The trader's CIK number is 1394936.
At the time of the last reporting, Brannelly Paul was the VP Finance, Treasure of Collegium Pharmaceutical, Inc. (stock ticker symbol COLL).
Also see all insider trading activities at Collegium Pharmaceutical, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | KPTI | 2,500 | $67,766 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | SIRT | 0 | $0 | 19,643 | $248,313 | 14,643 | $6,150 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | COLL | 0 | $0 | 10,000 | $279,250 | 0 | $0 |
| 2017 | COLL | 10,000 | $91,800 | 0 | $0 | 0 | $0 |
1. Karyopharm Therapeutics Inc. (KPTI)
2. Sirtris Pharmaceuticals, Inc. (SIRT)
3. Collegium Pharmaceutical, Inc (COLL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-05-15 | KPTI | Buy | 700 | 25.95 | 18,165 |
| 2014-05-14 | KPTI | Buy | 800 | 26.93 | 21,544 |
| 2014-05-13 | KPTI | Buy | 1,000 | 28.06 | 28,057 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-05-28 | SIRT | Option Ex | 14,643 | .42 | 6,150 |
| 2008-02-06 | SIRT | Sale | 6,547 | 12.30 | 80,541 |
| 2008-01-24 | SIRT | Sale | 6,548 | 12.81 | 83,886 |
| 2008-01-24 | SIRT | Sale | 6,548 | 12.81 | 83,886 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-21 | COLL | Sale | 10,000 | 27.93 | 279,250 |
| 2017-05-12 | COLL | Buy | 10,000 | 9.18 | 91,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brannelly Paul (VP Finance, Treasure of Collegium Pharmaceutical, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.